• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.

作者信息

Anand Shuchi, Montez-Rath Maria E, Han Jialin, Garcia Pablo, Cadden LinaCel, Hunsader Patti, Kerschmann Russell, Beyer Paul, Dittrich Mary, Block Geoffrey A, Boyd Scott D, Parsonnet Julie, Chertow Glenn M

机构信息

Division of Nephrology, Department of Medicine, Stanford University, Stanford, California.

Ascend Clinical Laboratory, Redwood City, California.

出版信息

J Am Soc Nephrol. 2021 Oct;32(10):2435-2438. doi: 10.1681/ASN.2021050611. Epub 2021 Jun 11.

DOI:10.1681/ASN.2021050611
PMID:34117129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8722791/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d1/8722791/66fe306f43e0/ASN.2021050611absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d1/8722791/66fe306f43e0/ASN.2021050611absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0d1/8722791/66fe306f43e0/ASN.2021050611absf1.jpg

相似文献

1
Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.接受透析治疗的患者对新冠疫苗接种的抗体反应。
J Am Soc Nephrol. 2021 Oct;32(10):2435-2438. doi: 10.1681/ASN.2021050611. Epub 2021 Jun 11.
2
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
3
Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.血液透析患者接种mRNA-1273新冠病毒疫苗后的抗体反应：有或无既往新冠病毒感染史的对比
Clin J Am Soc Nephrol. 2021 Aug;16(8):1258-1260. doi: 10.2215/CJN.04080321. Epub 2021 May 24.
4
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.慢性透析患者 COVID-19 疫苗接种的免疫原性。
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
5
Active vitamin D analog and SARS-CoV-2 IgG after BNT162b2 vaccination in patients with hemodialysis: Correspondence.血液透析患者接种BNT162b2疫苗后活性维生素D类似物与新型冠状病毒2型免疫球蛋白G的关系：通信
Ther Apher Dial. 2024 Oct;28(5):810-811. doi: 10.1111/1744-9987.14171. Epub 2024 May 27.
6
Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.实体瘤患者在接种 SARS-CoV-2 mRNA 疫苗后血清转化。
Cancer Discov. 2021 Sep;11(9):2122. doi: 10.1158/2159-8290.CD-RW2021-099. Epub 2021 Jul 16.
7
Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.透析患者对基于mRNA与腺病毒载体的SARS-CoV-2疫苗的体液反应。
Clin J Am Soc Nephrol. 2021 Nov;16(11):1720-1722. doi: 10.2215/CJN.06450521. Epub 2021 Jul 26.
8
Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers.疫苗类型和既往 SARS-CoV-2 感染与医护人员接种疫苗后症状和抗体测量的关联。
JAMA Intern Med. 2021 Dec 1;181(12):1660-1662. doi: 10.1001/jamainternmed.2021.4580.
9
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.mRNA-1273 新冠病毒疫苗在血液透析患者中的安全性和免疫原性。
Front Immunol. 2021 Jun 16;12:704773. doi: 10.3389/fimmu.2021.704773. eCollection 2021.
10
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients.血液透析患者对 SARS-CoV-2 BNT162b2 mRNA 疫苗的体液和细胞应答。
BMC Immunol. 2021 Oct 19;22(1):70. doi: 10.1186/s12865-021-00458-0.

引用本文的文献

1
The Anti-Nucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection for Hemodialysis Patients.抗核衣壳IgG抗体作为血液透析患者感染新型冠状病毒的标志物
Vaccines (Basel). 2025 Jul 13;13(7):750. doi: 10.3390/vaccines13070750.
2
Discrepancy in SARS-CoV-2 Infection Status Among PCR, Serological, and Cellular Immunity Assays of Nucleocapsids: A Historical Cohort Study.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）核衣壳蛋白的聚合酶链反应（PCR）、血清学和细胞免疫检测中感染状态的差异：一项历史性队列研究
Vaccines (Basel). 2025 Feb 28;13(3):259. doi: 10.3390/vaccines13030259.
3
Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic.
移植受者和血液透析患者对SARS-CoV-2疫苗的抗体反应：来自多米尼加共和国的数据。
Vaccines (Basel). 2024 Nov 23;12(12):1312. doi: 10.3390/vaccines12121312.
4
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients.初治和曾感染过SARS-CoV-2的血液透析患者对COVID-19疫苗的反应受不同风险因素的影响。
Vaccine. 2025 Jan 12;44:126544. doi: 10.1016/j.vaccine.2024.126544. Epub 2024 Nov 29.
5
Determinants of protective humoral response to mRNA-1273 and BNT162b2 vaccines in peritoneal dialysis patients: a prospective cohort study.mRNA-1273 和 BNT162b2 疫苗在腹膜透析患者中诱导保护性体液免疫反应的决定因素：一项前瞻性队列研究。
BMC Nephrol. 2024 Oct 31;25(1):391. doi: 10.1186/s12882-024-03789-3.
6
Network Analysis of Dysregulated Immune Response to COVID-19 mRNA Vaccination in Hemodialysis Patients.血液透析患者对新冠mRNA疫苗免疫反应失调的网络分析
Vaccines (Basel). 2024 Oct 7;12(10):1146. doi: 10.3390/vaccines12101146.
7
Hesitation towards COVID-19 booster vaccination among dialysis patients: a cross-sectional study in Taizhou, China.中国泰州一项横断面研究显示，透析患者对接种 COVID-19 加强针犹豫不决。
BMC Infect Dis. 2024 Oct 2;24(1):1095. doi: 10.1186/s12879-024-09917-6.
8
Immune Response after Anti-SARS-CoV-2 mRNA Vaccination in Relation to Cellular Immunity, Vitamin D and Comorbidities in Hemodialysis Patients.抗SARS-CoV-2 mRNA疫苗接种后血液透析患者的免疫反应与细胞免疫、维生素D和合并症的关系
Microorganisms. 2024 Apr 25;12(5):861. doi: 10.3390/microorganisms12050861.
9
SARS-CoV-2 Antibody Seroprevalence and Humoral Response to Vaccination in Patients Undergoing Maintenance Hemodialysis: A Prospective Cohort Study.接受维持性血液透析患者中SARS-CoV-2抗体血清流行率及对疫苗的体液反应：一项前瞻性队列研究。
Indian J Nephrol. 2024 Mar-Apr;34(2):129-133. doi: 10.4103/ijn.ijn_7_23. Epub 2023 Aug 4.
10
Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine.维持性血液透析患者对COVID-19 mRNA疫苗的转录组免疫反应改变。
Elife. 2024 Apr 24;13:e83641. doi: 10.7554/eLife.83641.